Product Portfolio

Bioreactors and Fermenters

Learn More

Cell Culture Media

Learn More

Cell Selection and Retrieval

Learn More

Flow Cytometry

Learn More

Fluid Management

Learn More

Industrial Microbiology

Shop Now
A scientist uses a Sartorius Sartolab® RF | BT Filter System

Lab Filtration and Purification

Shop Now

Live Cell Imaging and Analysis

Learn More


Learn More

Process Analytical Technology (PAT) and Data Analytics

Learn More
chromatography membranes and chromatography resins for downstream processes

Process Chromatography

Learn More

Process Filtration

Learn More

Protein Analysis

Learn More
Arium® Water Purification Systems

Water Purification

Learn More
Lab weighing product portfolio Sartorius


Learn More

Skip The Wait: Purchase In-Stock Products Now

Whether your focus is life science research or biopharmaceutical manufacturing, Sartorius offers a wide range of instruments and consumables available with short lead times to help you and your workflow stay on track.

Shop Bioprocess Solutions

Shop Laboratory Products

New Products

Octet® SF3 SPR

High Sensitivity. High Throughput. Low Maintenance.

Meet the new Octet® SF3 SPR system that allows users to generate high-quality binding kinetics and affinity data in a fraction of the time.

Discover Now

10x Faster Aseptic Filling with Single-Use Plug and Play Setup

The Linkit® AX simplifies aliquoting with an aseptic system that simultaneously fills 10 single-use bags quickly.

Discover Now

Sartorius Blogs

Partner of Life Science Research and the Biopharmaceutical Industry

Many diseases, such as cancer, dementia or inflammatory diseases, are still incurable. Sartorius is helping biotech scientists and engineers across the entire globe to develop and manufacture medications from the first idea to production. So more people will have access to better medicine.

About Sartorius

Company News

Sartorius agrees with BICO on strategic cooperation

December 8, 2022 – Sartorius has agreed with Sweden-based BICO Group on strategic cooperation as well as a 10 percent capital investment.

Read Press Release

Investor Relations

Explore More